☆ 4.6 Article

The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia

PUBLIC HEALTH (2023)

Related references

Note: Only part of the references are listed.

Article Substance Abuse

The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia

Kasun Rathnayake et al.

Summary: The study found that COVID-19 public health measures in Victoria state, Australia, were associated with increases in the price of methamphetamine and decreases in its use frequency, especially during the period of the most intense restrictions. It was also observed that although prices decreased after the restrictions were lifted, they remained higher than pre-COVID-19 levels.

ADDICTION (2023)

Add to Collection

Article Substance Abuse

Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia

Tina Lam et al.

Summary: This study found limited evidence of unintentional fentanyl use among people who regularly inject heroin in Sydney and Melbourne, Australia, suggesting very little illicit fentanyl in Australian drug markets accessed by supervised injecting facilities attendees. The study demonstrates the feasibility of quick onsite testing to cost-effectively screen large samples for fentanyl; however, the high false positive rate emphasizes the need for confirmation of positive tests through advanced analytical techniques.

ADDICTION (2022)

Add to Collection

Article Substance Abuse

Drug markets and COVID-19: A spatiotemporal study of drug offence detection rates in Brisbane, Australia

Jason L. Payne et al.

Summary: This study explores the increase in illicit drug offence detection rates in Brisbane, Queensland during the COVID-19 lockdown. The study finds that while the increase was modest in most places, it was widespread throughout the city. The study also identifies several locations where the drug offence detection rate exceeded the prediction.

INTERNATIONAL JOURNAL OF DRUG POLICY (2022)

Add to Collection

Review Substance Abuse

Health service utilisation and access for people who inject drugs during COVID-19

Henrietta Efunnuga et al.

Summary: This study examined the impact of COVID-19 restrictions on access to harm reduction and drug treatment services for people who inject drugs in Melbourne, Victoria. The findings revealed that the restrictions led to service disruptions, making it difficult to access sterile injecting equipment, increased the risk of arrest by police, and exacerbated social isolation. However, the study also identified improvements in opioid agonist therapy prescriptions.

DRUG AND ALCOHOL REVIEW (2022)

Add to Collection

Article

Toxicity of heroin laced with synthetic opioid β-U10 and etizolam

Matthew Di Rago et al.

Toxicologie Analytique et Clinique (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services

S. Croxford et al.

Summary: This study aimed to describe the impact of the COVID-19 pandemic on people who inject drugs in England, Wales, and Northern Ireland. Preliminary findings showed negative impacts on the health, behaviors, and access to essential services in this population. Continued monitoring through surveillance and research is necessary to understand the subsequent effects of COVID-19 on blood-borne virus transmission and health inequalities.

PUBLIC HEALTH (2021)

Add to Collection

Article Substance Abuse

Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs

Joanna M. Kesten et al.

Summary: The study found significant impacts and challenges of the COVID-19 pandemic on the lives of PWID, including concerns about public health measures, changes in service delivery, and shifts in drug use patterns and risk behavior. While rapid adaptations to services to mitigate COVID-19 risks were appreciated, barriers to access still need further attention.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

Add to Collection

Article Psychiatry

Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

Seyed Ramin Radfar et al.

Summary: The COVID-19 pandemic has had a significant impact on SUD treatment and harm-reduction services globally, with issues such as the continuation of core medical and psychiatric care, lack of business continuity plans in some countries, and shortages of methadone or buprenorphine supplies. Overdose prevention interventions and outreach services were also negatively impacted in a number of countries. Strategies for future pandemics should include generating business continuity plans, maintaining evidence-based interventions, ensuring adequate medication supplies, integrating harm reduction programs, and considering vulnerable groups like immigrants and refugees.

FRONTIERS IN PSYCHIATRY (2021)

Add to Collection

Article Substance Abuse

Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia

Amanda Roxburgh et al.

Summary: The COVID-19 crisis has had profound impacts on health service provision, particularly on supervised injecting facilities and drug consumption rooms. Despite potential risks, two supervised injecting facilities in Australia have remained open during the pandemic, implementing strategies to continue providing services to drug users.

HARM REDUCTION JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak

Matteo Chinazzi et al.

SCIENCE (2020)

Add to Collection

Article Substance Abuse

Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type

Elodie Lefrancois et al.

DRUG AND ALCOHOL DEPENDENCE (2020)

Add to Collection

Article Substance Abuse

Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs

M. J. Stowe et al.

JOURNAL OF ADDICTION MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Impact of COVID-19 pandemic on mental health: An international study

Andrew T. Gloster et al.

PLOS ONE (2020)

Add to Collection

Article Substance Abuse

The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England

Mark Whitfield et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

Add to Collection

Article Substance Abuse

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

Adrian Dunlop et al.

HARM REDUCTION JOURNAL (2020)

Add to Collection

Article Substance Abuse

Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre

Amanda Roxburg et al.

DRUG AND ALCOHOL DEPENDENCE (2017)

Add to Collection

Article Social Sciences, Mathematical Methods

Conducting interrupted time-series analysis for single- and multiple-group comparisons

Ariel Linden

STATA JOURNAL (2015)

Add to Collection

Article Substance Abuse

Characteristics of drug-related hospital separations in Australia

Amanda Roxburgh et al.

DRUG AND ALCOHOL DEPENDENCE (2008)

Add to Collection

Article Substance Abuse

Changes in patterns of drug use among injecting drug users following changes in the availability of heroin in New South Wales, Australia

A Roxburgh et al.

DRUG AND ALCOHOL REVIEW (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.